Where does Cresilon's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cresilon's 8 recorded funding rounds.

Premier Alternatives

Cresilon

New York, NY · Founded 2012 · Privately Held (backing)

Developer of hemostatic products designed to support the natural clotting and promote wound healing. Cresilon is based in New York, NY and was founded in 2012. Its last reported valuation was $340 million in Apr 2024. It has raised $160 million across 8 recorded rounds; the latest was a $29 million early-stage round in Apr 2026.

Last reported valuation

$340.0M

Oct 2026

Priced at

—

Total raised

$159.5M

Last round

Early Stage VC

Apr 2026

Cap table — not yet on record

Cresilon's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Cresilon with a free account

·The complete investor list: 20 names
·Watch Cresilon: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Cresilon

Where does Cresilon's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cresilon's 8 recorded funding rounds.